Tag: Eris
Browse our exclusive articles!
Eris Lifesciences to acquire remaining 30% in Swiss Parenterals for ₹423 crore
Eris Lifesciences Ltd has moved to fully consolidate its injectable manufacturing subsidiary, Swiss Parenterals, by acquiring the remaining 30% stake for ₹423.3 crore, the...
Eris Lifesciences gets ₹17 crore GST show cause notice over Novartis trademark deal
Drug firm Eris Lifesciences Limited on Friday (August 22) said it has received a show cause cum demand notice from the Directorate General of...
Eris Lifesciences transfers ₹861.91 crore holdings to subsidiary as part of internal restructuring
Eris Lifesciences Ltd on Thursday (March 6) said it has transferred its 100% holdings in Eris Oaknet Healthcare Private Ltd (EOHPL) and Aprica Healthcare...
